| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income (expense), net | -18,899 | -9,451 | 1,660 | 4,275 |
| Net loss | -26,675 | -16,295 | -6,531 | -5,481 |
| Earnings per share, basic | -0.74 | -0.45 | -0.18 | -0.15 |
| Earnings per share, diluted | -0.74 | -0.45 | -0.2 | -0.15 |
| Weighted average number of shares outstanding, basic | 36,226,285 | 36,193,479 | 36,184,802 | 36,180,124 |
| Weighted average number of shares outstanding, diluted | 36,226,285 | 36,193,479 | 59,478,662 | 36,180,124 |
Armata Pharmaceuticals, Inc. (ARMP)
Armata Pharmaceuticals, Inc. (ARMP)